Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B - Aix-Marseille Université Access content directly
Journal Articles JCO precision oncology Year : 2019

Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B

Domains

Cancer
No file

Dates and versions

hal-03623688 , version 1 (29-03-2022)

Identifiers

Cite

Lorène Seguin, Max Chaffanet, Séverine Garnier, José Adélaïde, Nadine Carbuccia, et al.. Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B. JCO precision oncology, 2019, 3, pp.1-9. ⟨10.1200/po.18.00362⟩. ⟨hal-03623688⟩

Collections

CNRS UNIV-AMU CRCM
6 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More